Role of antioxidants in reducing heart disease in HIV-infected patients

Yingying Liu, Ronald R Watson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cardiovascular disease (CVD) is an important complication of human immunodeficiency virus (HIV) infection. It is now being reported with greater frequency, since a necropsy study first described cardiac involvement in an acquired immune deficiency syndrome (AIDS) patient (1). So far, cardiac abnormalities are found at autopsy in two-thirds of patients with AIDS, but they are often not detected by clinical examination. Although the cause and pathogenesis of CVD remain unresolved in many situations, opportunistic infections, vasculitis, hypoxia, catecholamine excess, and nutritional deficiencies have been suggested (2).

Original languageEnglish (US)
Title of host publicationAIDS and Heart Disease
PublisherCRC Press
Pages235-242
Number of pages8
ISBN (Electronic)9780203021897
ISBN (Print)9780824741150
StatePublished - Jan 1 2004

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Role of antioxidants in reducing heart disease in HIV-infected patients'. Together they form a unique fingerprint.

  • Cite this

    Liu, Y., & Watson, R. R. (2004). Role of antioxidants in reducing heart disease in HIV-infected patients. In AIDS and Heart Disease (pp. 235-242). CRC Press.